Oncology & Hematology
Proactive AE Management in Oncology Trials: Moving Medical Strategy Upstream
Advances in oncology are expanding what is therapeutically possible while also introducing new complexity into clinical trial execution. Immune-based therapies, cellular therapies, bispecifics, and other emerging modalities can produce toxicity profiles that differ substantially from those associated with traditional cytotoxic...